Literature DB >> 15029984

Management of Barrett's oesophagus in 2001 in Ireland.

A Moss1, E Clarke, J Crowe, J Lennon, P Mac Mathuna.   

Abstract

BACKGROUND: Endoscopic surveillance of patients with Barrett's oesophagus is recommended to detect early carcinoma. The practice patterns of endoscopists since the publication of more recent management guidelines remain unknown.
METHODS: All endoscopists (n=68) in the Irish Medical Directory and their trainees were sent a postal questionnaire on Barrett's surveillance.
RESULTS: Fifty-five per cent (30/54) perform surveillance on all patients with Barrett's oesophagus and 38% on selected patients. In patients with no dysplasia, repeat endoscopy was more commonly practiced annually (28/54) than every two to three years (23/54). Surgeons were more likely to perform surveillance annually than gastroenterologists (75% vs 40%). Only 26% of endoscopists took four-quadrant biopsies every 2 cm. Intervention was recommended by a majority (28/54) of endoscopists in a patient with high grade dysplasia. A majority of respondents (47/54) would have surveillance if they were found to have Barrett's oesophagus.
CONCLUSION: Most endoscopists in Ireland do not adhere to recent guidelines in their management of Barrett's oesophagus. Surgical endoscopists perform surveillance more frequently than their medical colleagues.

Entities:  

Mesh:

Year:  2003        PMID: 15029984     DOI: 10.1007/BF02915284

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  15 in total

1.  Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma.

Authors:  J W van Sandick; J J van Lanschot; B W Kuiken; G N Tytgat; G J Offerhaus; H Obertop
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

2.  Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology.

Authors:  R E Sampliner
Journal:  Am J Gastroenterol       Date:  1998-07       Impact factor: 10.864

3.  Surveillance of Barrett's esophagus: a need for guidelines?

Authors:  R Ackroyd; S E Wakefield; J L Williams; C J Stoddard; M W Reed
Journal:  Dis Esophagus       Date:  1997-07       Impact factor: 3.429

Review 4.  Management of dysplasia in the columnar-lined esophagus.

Authors:  D S Levine
Journal:  Gastroenterol Clin North Am       Date:  1997-09       Impact factor: 3.806

5.  The role of endoscopy in the surveillance of premalignant conditions of the upper gastrointestinal tract. Guidelines for clinical application.

Authors: 
Journal:  Gastrointest Endosc       Date:  1988 May-Jun       Impact factor: 9.427

6.  Barrett's oesophagus: results from a 13-year surveillance programme.

Authors:  K Bani-Hani; H Sue-Ling; D Johnston; A T Axon; I G Martin
Journal:  Eur J Gastroenterol Hepatol       Date:  2000-06       Impact factor: 2.566

7.  Surveillance for Barrett's oesophagus in the UK.

Authors:  A M Smith; C A Maxwell-Armstrong; N T Welch; J H Scholefield
Journal:  Br J Surg       Date:  1999-02       Impact factor: 6.939

8.  Cost effectiveness of detecting Barrett's cancer.

Authors:  T A Wright; M R Gray; A I Morris; I T Gilmore; A Ellis; H L Smart; M Myskow; J Nash; R J Donnelly; A N Kingsnorth
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

9.  Adenocarcinoma in Barrett's oesophagus: an overrated risk.

Authors:  A H Van der Veen; J Dees; J D Blankensteijn; M Van Blankenstein
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

10.  A study to examine agreement between endoscopy and histology for the diagnosis of columnar lined (Barrett's) esophagus.

Authors:  G M Woolf; R H Riddell; E J Irvine; R H Hunt
Journal:  Gastrointest Endosc       Date:  1989 Nov-Dec       Impact factor: 9.427

View more
  1 in total

1.  Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus: a multicenter study.

Authors:  Seth D Crockett; Isaac M Lipkus; Stephanie D Bright; Richard E Sampliner; Kenneth K Wang; Vikram Boolchand; Lori S Lutzke; Nicholas J Shaheen
Journal:  Gastrointest Endosc       Date:  2011-11-17       Impact factor: 9.427

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.